Single Peptides · Exact presentation
MGF · 5 mg Vial
MGF · 5 mg Vial is an exact single peptide or compound entry. This strength is kept separate because concentration and calculations depend on vial amount.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Dosing & Reconstitution Guide
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Standard / Gradual Approach (3 mL = ~1.67 mg/mL)
The source chart summarizes “100 mcg–300 mcg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Standard / Gradual Approach (3 mL = ~1.67 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Week 1 | 100 mcg (0.1 mg) | 6 units (0.06 mL) |
| Week 2 | 150 mcg (0.15 mg) | 9 units (0.09 mL) |
| Week 3 | 200 mcg (0.2 mg) | 12 units (0.12 mL) |
| Week 4 | 250 mcg (0.25 mg) | 15 units (0.15 mL) |
| Weeks 5–8 | 300 mcg (0.3 mg) | 18 units (0.18 mL) |
Reconstitution Steps
For a 5 mg presentation, the reference concentration of 1.67 mg/mL mathematically corresponds to 2.994 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 1.67 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0167 mg at this concentration.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
It relates to the growth-hormone-releasing hormone, secretagogue receptor, and GH/IGF-1 axis. Each molecule acts at a different point and should not be treated as interchangeable.
Potential Benefits & Side Effects
GH/IGF-1 signaling is systemic and may carry metabolic, endocrine, and proliferative risks. No clinical regimen is provided here.
Source trail
Scientific references and source discovery
- PeptideDosages — exact MGF · 5 mg Vial entrysecondary-structure
- PubMed — literature search for MGFprimary-discovery
- ClinicalTrials.gov — study search for MGFtrial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference